Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study.
Maria S Ruiz de AdanaMaria Rosa Alhambra-ExpósitoAraceli Muñoz-GarachInmaculada Gonzalez-MoleroNatalia ColomoIsabel Torres-BareaManuel Aguilar-DiosdadoFlorentino CarralManuel SerranoMaria A Martínez-BroccaAna DuranRafael Palomaresnull nullPublished in: Diabetes care (2019)
The use of telemedicine in patients with type 1 diabetes with HbA1c <8% (<64 mmol/mol) provides similar efficacy and safety outcomes as face-to-face visits.